Other The innovators working to make in vivo cell therapy a reality Pharmaceutical TechnologyAs in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.OtherGene Therapy PlatformRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaceutical Technology As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability. OtherGene Therapy PlatformRead full story Post navigation Previous: Trump names Erica Schwartz to fill leadership void at CDCNext: Aligos and Xiamen Amoytop sign deal for HBV therapy Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
